Søren Bentzen

Pulmonary and Respiratory Medicine · 2000–2019

A researcher in the Science corpus: 12 papers; trusts 11 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Pulmonary and Respiratory Medicine — 14 citations into it
• Molecular Biology — 13 citations into it
• Radiology, Nuclear Medicine and Imaging — 13 citations into it; #2,451 of 3,265 by trust here, #1,054 by citations
• Surgery — 11 citations into it
• Cancer Research — 10 citations into it
• Pathology and Forensic Medicine — 7 citations into it
• Genetics — 6 citations into it

Whom Søren Bentzen trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. S. Delanian
2. Raghu Kalluri
3. Xin-Hua Feng
4. Joel Hirschhorn
5. A. Leask
6. Adrian L. Harris
7. William Y S Wang
8. H. Herschman
9. J. Lefaix
10. Eric G. Neilson

Who trusts Søren Bentzen overall

1. Adrian C. Begg
2. Michael Baumann
3. F. Stewart
4. Harald Paganetti
5. P. Vaupel

Papers from Søren Bentzen's perspective

Ordered by how strongly the researchers Søren Bentzen trusts endorse each paper. Same corpus, a different order for every researcher.

1. Evidence that fibroblasts derive from epithelium during tissue fibrosis. (Journal of Clinical Investigation)
2. Signal Transduction by the TGF-β Superfamily (Science)
3. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. (Free Radical Biology & Medicine)
4. Epithelial-mesenchymal transition and its implications for fibrosis. (Journal of Clinical Investigation)
5. TGF‐β signaling and the fibrotic response (The FASEB Journal)
6. Hypoxia — a key regulatory factor in tumour growth (Nature Reviews. Cancer)
7. SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
8. Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
9. Nonparametric Estimation from Incomplete Observations
10. TGF-β signaling: positive and negative effects on tumorigenesis

Their papers

• Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma (2019)
• Radiation oncology in the era of precision medicine (2016) — 768 citations
• Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. (2013) — 857 citations
• Radiation Dose Volume Effects in the Lung (2010) — 1,056 citations
• The Use of Normal Tissue Complication Probability (NTCP) Models in the Clinic (2010) — 1,722 citations
• Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues (2010) — 1,204 citations
• The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial (2008) — 1,069 citations
• The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial (2008) — 1,285 citations
• Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology (2006) — 1,079 citations
• Theragnostic imaging for radiation oncology: dose-painting by numbers. (2005) — 422 citations
• Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. (2005) — 942 citations
• Morbidity Related to Axillary Irradiation in the Treatment of Breast Cancer (2000) — 106 citations